XML 89 R77.htm IDEA: XBRL DOCUMENT v3.22.1
Line of Credit (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2022
Jan. 26, 2022
Jan. 25, 2022
Jun. 30, 2021
Debt            
Period of notice required before prepaying the debt instrument     5 days      
Interest expense   $ 400,000        
Legal and other fees     $ 100,000      
Aggregate borrowing capacity       $ 3,500,000 $ 1,000,000.0  
Amortization of deferred financing costs   100,000 400,000      
Other Noncurrent Assets [Member]            
Debt            
Unamortized debt issuance expense   100,000 $ 100,000      
Revolving Credit Facility [Member]            
Debt            
Maximum borrowing capacity       $ 12,500,000 $ 25,000,000.0  
Event Occurs on or before January 26, 2023 [Member]            
Debt            
Commitment fee percentage     2.00%      
Event Occurs After January 26, 2023 But On or Before January 26, 2024 [Member]            
Debt            
Commitment fee percentage     1.00%      
Event Occurs After January 26, 2024 But on or Before January 26, 2025 [Member]            
Debt            
Commitment fee percentage     0.50%      
Neos Therapeutics, Inc. | Loan Agreement            
Debt            
Maximum borrowing capacity $ 25,000,000.0          
Maximum borrowing capacity portion available for short-term swingline loans $ 2,500,000          
Percentage of eligible accounts receivable against which short-term swingline loans may be made 85.00%          
Unused capacity commitment fee percentage 0.50%          
Interest expense $ 28,000          
Outstanding amount   $ 3,400,000 $ 3,400,000     $ 7,900,000
Neos Therapeutics, Inc. | Loan Agreement | London Interbank Offered Rate (LIBOR)            
Debt            
Basis spread on variable rate 4.50%